US 10351589
3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders
granted A61KA61K31/57A61K45/06
Quick answer
US patent 10351589 (3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders) held by Umecrine Cognition AB expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Umecrine Cognition AB
- Grant date
- Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/57, A61K45/06, A61P, A61P1/16